Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
D000328:Adult; D000368:Aged; D001792:Blood Platelets; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D002813:Chondrosarcoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000627:therapeutic use* / Q000633:toxicity
D014747:Vinblastine